Blueprint Medicines Corp 4
4 · Blueprint Medicines Corp · Filed Apr 14, 2016
Insider Transaction Report
Form 4
Lengauer Christoph
Chief Scientific Officer
Transactions
- Sale
Common Stock
2016-04-13$20.01/sh−15,872$317,599→ 56,657 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.08 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.